跳至主要内容
临床试验/CTRI/2024/04/066246
CTRI/2024/04/066246尚未招募2 期

A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines on glycemic control in type II diabetes mellitus in the mutual context of standard care - Nil

Department of Science and Technology and Biotechnology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Cases suffering from diabetes mellitus type II (2021 ICD-10-CM diagnosis code E11.9)
  • 2) FBS more than 126 mg/dl; PPBS more than 200 mg per dl; HbA1c% more than 6.5 (ADA criteria)
  • 3) Age between 18 and 65 years
  • 4) Participants of either sex including transgender
  • 5) Literate patients; ability to read and write in Bengali and/or English

排除标准

  • 1) Excessive blood glucose, FBS more than 300 mg per dl, PPBS more than 450 mg per dl
  • 2) Participants with type I DM
  • 3) Diagnosed cases of unstable psychiatric illness or other uncontrolled or life threatening illness affecting the quality of life or any organ failure
  • 4) Pregnant, puerperal, and lactating women
  • 5) Self-reported immune-compromised state
  • 6) Tobacco, alcohol, or any kind of substance abuse and/or dependence
  • 7) Undergoing homoeopathic treatment for any chronic disease within last 6 months
  • 8) Participants denying written informed consent

研究者

发起方
Department of Science and Technology and Biotechnology

相似试验

Homeopathic medicines for diabetes | 临床试验